AOAC SPADA Meeting

What is the objective and points to consider for the WG • Objective: Evolve a standard for use of in silico approaches in assay development • Set parameters needed for in silico approach • What are the steps that can be modified/eliminated? • Cost? • What are the broad categories of information to be captured? • What is the outline of the document- this is not the usual run of the mill SMPR. • Document type: Standards/ guidelines/ recommendations/ manuscript • What is the venue to publish? AOAC, ASM Science, Genomics, Techniques

2018_10_17_SPADA_Brief

25

CONTACT US

Bruce Goodwin Joint Product Leader bruce.g.goodwin4.civ@mail.mil Bryan Necciai

Assistant Product Manager bryan.d.necciai.civ@mail.mil Shanmuga Sozhamannan, Ph. D Technical Coordinator email: shanmuga.sozhamannan.ctr@mail.mil https://www.ncbi.nlm.nih.gov/pubmed/?term=Sozhamannan

This work was funded by DUSA-TE and JPEO JPM Guardian, DBPAO

2018_10_17_SPADA_Brief

UNCLASSIFIED

26